GB8603031D0 - Pharmaceutical formulations - Google Patents

Pharmaceutical formulations

Info

Publication number
GB8603031D0
GB8603031D0 GB868603031A GB8603031A GB8603031D0 GB 8603031 D0 GB8603031 D0 GB 8603031D0 GB 868603031 A GB868603031 A GB 868603031A GB 8603031 A GB8603031 A GB 8603031A GB 8603031 D0 GB8603031 D0 GB 8603031D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical formulations
formulations
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB868603031A
Other versions
GB2170710A (en
GB2170710B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Cancer Research
Original Assignee
Institute of Cancer Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Cancer Research filed Critical Institute of Cancer Research
Publication of GB8603031D0 publication Critical patent/GB8603031D0/en
Publication of GB2170710A publication Critical patent/GB2170710A/en
Application granted granted Critical
Publication of GB2170710B publication Critical patent/GB2170710B/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
GB8603031A 1985-02-08 1986-02-07 Improvements relating to pharmaceutical formulations Expired GB2170710B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858503221A GB8503221D0 (en) 1985-02-08 1985-02-08 Pharmaceutical formulations

Publications (3)

Publication Number Publication Date
GB8603031D0 true GB8603031D0 (en) 1986-03-12
GB2170710A GB2170710A (en) 1986-08-13
GB2170710B GB2170710B (en) 1989-08-23

Family

ID=10574137

Family Applications (2)

Application Number Title Priority Date Filing Date
GB858503221A Pending GB8503221D0 (en) 1985-02-08 1985-02-08 Pharmaceutical formulations
GB8603031A Expired GB2170710B (en) 1985-02-08 1986-02-07 Improvements relating to pharmaceutical formulations

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB858503221A Pending GB8503221D0 (en) 1985-02-08 1985-02-08 Pharmaceutical formulations

Country Status (1)

Country Link
GB (2) GB8503221D0 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0419890A3 (en) * 1989-09-29 1991-05-29 American Cyanamid Company Stable pharmaceutical formulations for antineoplastic compounds having more than one ethyleneimine group, and method

Also Published As

Publication number Publication date
GB8503221D0 (en) 1985-03-13
GB2170710A (en) 1986-08-13
GB2170710B (en) 1989-08-23

Similar Documents

Publication Publication Date Title
ZA868249B (en) Pharmaceutical preparation
GB2174904B (en) Vasculoprotecting pharmaceutical compositions
GB8618847D0 (en) Pharmaceutical formulations
GB2171600B (en) Pharmaceutical compositions
GB8602625D0 (en) Pharmaceutical compositions
EP0197752A3 (en) Pharmaceutical compositions
GB8515170D0 (en) Pharmaceutical compositions
GB8500310D0 (en) Pharmaceutical preparation
GB8602602D0 (en) Pharmaceutical compositions
GB8623389D0 (en) Pharmaceutical formulations
GB8607848D0 (en) Pharmaceutical compositions
GB2182561B (en) Pharmaceutical compositions
GB8522327D0 (en) Pharmaceutical compositions
GB8523531D0 (en) Pharmaceutical compositions
GB8602601D0 (en) Pharmaceutical compositions
GB8603031D0 (en) Pharmaceutical formulations
GR871915B (en) Pharmaceutical formulations
GB8502887D0 (en) Pharmaceutical compositions
GB8521863D0 (en) Pharmaceutical formulations
GB8524653D0 (en) Pharmaceutical formulations
GB8530794D0 (en) Pharmaceutical formulation
GB8519741D0 (en) Pharmaceutical formulation
GB8502917D0 (en) Pharmaceutical formulation
GB8524811D0 (en) Pharmaceutical formulation
GB8421741D0 (en) Pharmaceutical formulations

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee